The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

We previously developed a multivariate model based on the RNA expression of 6 genes (LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2) that predicts survival in diffuse large B-cell lymphoma (DLBCL) patients. Since LMO2 emerged as the strongest predictor of superior outcome, we generated a monoclonal anti-LM...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Natkunam, Yasodha, Zhao, Shuchun, Mason, David Y., Chen, Jun, Taidi, Behnaz, Jones, Margaret, Hammer, Anne S., Hamilton Dutoit, Stephen, Lossos, Izidore S., Levy, Ronald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2007
Aiheet:
Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1794056/
https://ncbi.nlm.nih.gov/pubmed/17038524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-08-039024
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia